Internal Medicine, Endocrinology, Diabetes, & Metabolism · Butler, MO
NPI
1366624215
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
615 W Nursery St
Butler, MO, 64730
Phone (660) 200-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
686 services
Medicare patients, 2024
300
Average age 71
Drug cost, 2024
$2.6M
5,235 prescriptions
Company payments, 2025
$87.9
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Susana D'Amico was code 99214 (office e&m - established), 322 times for 183 patients. In total Susana D'Amico billed 686 services in 8 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 322 | 183 | $66.11 | $21K |
| 95251 Test - Miscellaneous | Facility | 155 | 88 | $25.50 | $3,952 |
| 99215 Office E&M - Established | Facility | 58 | 45 | $96.29 | $5,585 |
| 99213 Office E&M - Established | Facility | 56 | 46 | $40.77 | $2,283 |
| 99203 Office E&M - New | Facility | 50 | 50 | $52.29 | $2,614 |
| 99204 Office E&M - New | Facility | 43 | 43 | $91.51 | $3,935 |
By year: 2022 $38K for 511 services; 2023 $35K for 494 services; 2024 $40K for 686 services.
Medicare prescription drug claims, 2024
In 2024, the drug Susana D'Amico prescribed most often to Medicare patients was Ozempic (Semaglutide), with 648 prescriptions and refills. In total Susana D'Amico wrote 5,235 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 648 | 849 | 107 | $793K |
| Levothyroxine Sodium Generic | 471 | 912 | 94 | $3,884 |
| Farxiga Dapagliflozin Propanediol | 314 | 463 | 56 | $256K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 312 | 553 | 77 | $45K |
| Jardiance Empagliflozin | 261 | 415 | 50 | $242K |
| Trulicity Dulaglutide | 231 | 308 | 46 | $304K |
| Atorvastatin Calcium Generic | 210 | 432 | 52 | $1,240 |
| Tresiba Flextouch U-200 Insulin Degludec | 155 | 294 | 39 | $155K |
| Metformin Hcl Er Metformin Hcl | 152 | 352 | 41 | $1,179 |
| Rosuvastatin Calcium Generic | 131 | 274 | 31 | $1,118 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 123 | 185 | 38 | $33K |
| Humalog Kwikpen U-100 Insulin Lispro | 120 | 210 | 31 | $35K |
| Mounjaro Tirzepatide | 119 | 161 | 31 | $172K |
| Pioglitazone Hcl Generic | 115 | 259 | 25 | $913 |
| Novolog Flexpen Insulin Aspart | 109 | 198 | 36 | $30K |
Brand drugs: 3,202 claims; generic drugs: 1,688 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Susana D'Amico $87.9 ($87.9 in general payments such as food, travel and fees) from 2 companies. The largest payer was Dexcom, Inc. with $62.36.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.